BON 6-K
Bon Natural Life Ltd (BON)
UNITEDSTATES
SECURITIESAND EXCHANGE COMMISSION
WASHINGTON,D.C. 20549
FORM6-K
REPORTOF FOREIGN PRIVATE ISSUER
PURSUANTTO RULE 13a-16 OR 15d-16 OF THE
SECURITIESEXCHANGE ACT OF 1934
Forthe month of April 2025
CommissionFile Number 001-40517
BONNATURAL LIFE LIMITED
(Translation of registrant’s name into English)
Room601, Block C, Gazelle Valley, No.69, Jinye Road
High-TechZone, Xi’an, Shaanxi, China
People’sRepublic of China
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.
SupplyAgreement
On February 19, 2025, our subsidiary Xi’an App-Chem Bio (Tech) Co., Ltd (“App-Chem”) entered into a Supply Agreement (the “Agreement”) with Shanghai Yunsheng International Trading Co., Ltd. (“Shanghai Yunsheng”). Under the Agreement, App-Chem agreed to supply Shanghai Yunsheng with apple polyphenol health products, including (i) apple polyphenol for plant-based beverages; (ii) apple polyphenol plant-based protein powder beverage, and (iii) apple polyphenol tablet candy, which Shanghai Yunsheng will sell and distribute. The term of the Agreement is twenty-four (24) months.
App-Chem will be responsible for quality control such that all of its products are compliant with applicable national standards, and provide a Certification of Analysis (COA). App-Chem will also provide adequate transportation insurance.
Any quality claims from Shanghai Yunsheng must be submitted within two (2) months from the date on which they received the products. App-Chem is not liable for any quality issues arising from improper storage or contamination during unpacking or handling by Shanghai Yunsheng. If any quality discrepancy arises, a re-inspection shall be conducted by a mutually agreed-upon third-party. If the re-inspection confirms non-conformity, App-Chem shall bear all costs incurred.
App-Chem must receive full advanced payment from Shanghai Yunsheng for any products before such products are dispatched.
Either party that terminates the Agreement without justifiable reasons (as defined in the Agreement) or fails to fulfill its obligations under the Agreement shall compensate the other party with a liquidated damages equivalent to 20% of the total Agreement amount. Any lawsuits must be filed in a court located in the People’s Republic of China.
The foregoing is a summary of the material terms of the Agreement. The Agreement contains additional terms, covenants and conditions and should be reviewed in its entirety for additional information.
Exhibits
The following exhibits are included in this Form 6-K:
| Exhibit No. | Description of Exhibit |
|---|---|
| 10.1 | Translation<br> of Supply Agreement with Shanghai Yunsheng International Trading Co., Ltd. |
| 99.1 | Press Release dated April 11, 2025 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Date:<br> April 11, 2025 | Bon Natural Life Limited | |
|---|---|---|
| By: | /s/ Yongwei Hu | |
| Yongwei<br> Hu | ||
| Chairman<br> and Chief Executive Officer |
Exhibit10.1
ApplePolyphenol Project Cooperation Agreement
| Party A: Xi’an App-Chem Bio (Tech) Co., Ltd. | Agreement No.: BONYS20250219-01 |
|---|---|
| Party B: Shanghai Yunsheng International Trading Co., Ltd. | Place:<br>Xi’an |
| Date:<br> 2025.02.19 |
Xi’an App-Chem Bio(Tech) Co., Ltd. (NASDAQ: BON) is a supplier of natural health bioactive ingredients and health solutions. Party A specializes in the research, development, production, and sales of natural active ingredients, with a focus on the study and development of ingredients for personal health and care products. It is a globally leading supplier of apple polyphenol series products. Party A’s apple polyphenol series products are widely sold in China, Japan, South Korea, the United States, the European Union, and other countries and regions, known for their excellent quality and strong reputation.
Shanghai Yunsheng International Trading Co., Ltd. is a leading health product company in China, specializing in the development and market expansion of plant-based health products, natural protein health products, and related sectors. Party B possesses extensive experience in product development and channel distribution across sports and fitness, beauty, anti-aging product lines, and maintains a professional team with robust resources in new retail and e-commerce marketing domains.
Apple polyphenols are exceptional natural bioactive compounds with potent physiological activities, including weight management and lipid reduction, anti-aging effects, anti-inflammatory and anti-allergic properties, oral care benefits, as well as antimicrobial and antibacterial effects. These compounds demonstrate extensive applications in functional foods, personal care products, and related fields. As an outstanding natural active ingredient, apple polyphenols have exhibited explosive growth in market demand in recent years. Over the next 5-10 years, they are projected to surpass the $500 million threshold as a major natural bioactive ingredient in global markets.
Whereas, Party A and Party B have reached the following agreement regarding the collaboration on the Apple Polyphenol Project through amicable negotiations:
Party A shall supply Party B with apple polyphenol health product series, including three categories: apple polyphenol(70% active ingredients) for plant-based beverages; apple polyphenol plant-based protein powder beverage and apple polyphenol tablet candy.Party A shall exclusively handle product R&D and GMP manufacturing, while Party B assumes full responsibility for the sales and distribution of the products. The detailed terms and conditions are as follows:
I．Item，specifications,quantityand amount
| Item | Specifications | Price | Quantity | Total<br>amount<br><br> <br>(in<br> CNY 10K) |
|---|---|---|---|---|
| Apple<br> Polyphenol | 70% | 1200<br> yuan/kg | 18,000<br> kg | 21.6 |
| Apple<br> Polyphenol Plant Protein Solid Beverage | 500g/box | 215<br> yuan/box | 2,650,000<br> boxes | 56.975 |
| Apple<br> Polyphenol Tablet Candy | 30<br> tablets/box | 25<br> yuan/box | 450,000<br> boxes | 11.25 |
| Total<br> amount | 89.825 |
II．QualityStandards
Product Specifications: Party A shall monitor and control the product-related indicators in accordance with applicable national standards to warrant that the product quality is compliant, and provide a Certification of Analysis (COA) for each shipment batch.
Quality Dispute Period: Any quality claims must be submitted within 2 months from the date of dispatch. Party A shall not be liable for any quality issues arising from: 1)improper storage by the buyer, or 2) contamination,excessive bacteria, or moisture caused during unpacking or handling by the buyer.
III.Term of Cooperation
The term of cooperation is 24 months from the date of the agreement signing.
IV.Delivery Method and Location
Under this Agreement, Party B shall issue staggered shipping instructions to Party A, and Party A warrants timely fulfillment of all shipments per the agreed schedule. Goods shall be delivered to the domestic city designated by Party B, excluding the warehouse entry fees.
V.Packaging
The standard packaging for e-commerce shipments typically utilizes conventional carton boxes. If Party B requires specialized packaging specifications, they should notify Party A in advance and assume responsibility for any additional expenses incurred thereby.Party A shall provide full cooperation in accommodating such special packaging requirements.
VI.Payment
The full advance payment must be wire transferred by Party B in advance of any shipment.Upon confirmation of payment clearance, Party A is required to effect dispatch of goods.
VII.Responsibilities and Obligations of Both Parties
Party B shall guarantee that all products purchased from Party A are marketed and sold in full compliance with relevant national laws and regulations.Under no circumstances shall Party B engage in any illegal promotion and sales.
2. Party B shall effect payments as scheduled in accordance with the agreement herein.Should any delivery delay arise from Party B’s (a) untimely remittance, (b) failure to furnish timely shipping instructions, or (c) other material breaches under this agreement, the delivery schedule shall be automatically extended commensurate with the duration of such delay, with Party A fully exempt from contractual liability for such extended period.
3. Party A shall deliver the goods on time as required by Party B, ensuring that the packaging meets all necessary standards for safe and efficient logistics transportation.Party A shall be responsible for procuring adequate transportation insurance.
4. Should any quality discrepancy where the goods fail to meet the specifications outlined in Annex COA or the Quality Requirements of this Contract, a re-inspection shall be conducted by a mutually agreed-upon third-party.A tolerance of ±1% shall apply to the re-inspection results:if the tested values fall within this range, the goods shall be deemed compliant. If the re-inspection confirms non-conformity with Annex COA/Quality Requirements, Party A shall bear all costs incurred therefrom.
5. Either party that terminates the agreement without justifiable reasons or fails to fulfill its obligations shall compensate the other party with a liquidated damages equivalent to 20% of the total agreement amount.
VIII.Violation Liability
Both parties shall strictly perform their respective obligations in under this agreement. In case of force majeure that causes the contract to be unable to be executed or causes a delay in execution, both parties shall conduct specific consultations to determine the solution.
IX.Miscellaneous
Both parties shall resolve them through friendly consultations and may enter into a separate agreement for stipulation. During the execution of the contract, if there is an irreconcilable commercial dispute, either party may file a lawsuit with the people’s court located in the place where Party A is located.
This agreement shall come into effect upon execution by both parties with signatures and seals. It shall be made in quadruplicate, with each party holding two copies, and all copies shall have the same legal effect.
| Party<br>A: Xi’an App-Chem Bio (Tech) Co., Ltd.<br><br> <br>Official<br>Seal:<br><br> <br>Representative(signature):<br><br> <br>Date:<br> Feb. 19^th^,2025 | Party<br>B: Shanghai Yunsheng<br><br> <br>International<br>Trading Co., Ltd.<br><br> <br>Official<br>Seal:<br><br> <br>Representative(signature):<br><br> <br>Date:<br>Feb. 19^th^,2025 |
|---|
Exhibit99.1
BON Announces Apple Polyphenol Commercial Order Signed
XI’AN, China, April 11, 2025 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced a groundbreaking 24-month supply agreement worth $12M with Shanghai Yunsheng, China’s premier functional ingredients distributor, to co-develop next-generation apple polyphenol-infused health solutions. The partnership leverages BON’s patented extraction technology to deliver science-backed formulations combining antioxidant-rich apple polyphenols with plant-based proteins, proven to support weight management and metabolic health.
Protein supplements have evolved into a mainstream wellness staple over decades, cementing their role in fitness regimens, immune health protocols, and longevity-focused nutrition. The strategic incorporation of apple polyphenols into these formulations now unlocks targeted benefits—clinically validated lipid management, enhanced body composition outcomes, and mitigation of age-related muscle atrophy—positioning this innovation at the convergence of proven demand and novel functionality.
Early market validation proves compelling - comparable apple polyphenol blends have achieved blockbuster status since launch, selling over half a million units monthly and generating $40M in recurring revenue. Industry analysts note this reflects growing consumer willingness to pay premium pricing for validated “nutraceutical crossover” products.
“As one of the world’s premier apple polyphenol suppliers, we’re leveraging our vertically integrated supply chain to dominate this high-growth niche,” said Yongwei Hu, Chairman and CEO of the Company, “the company anticipates compounding revenue streams from the ingredient’s dual applications—both as a standalone nutraceutical and as a functional food additive—while maintaining disciplined margin control to maximize shareholder returns.”
AboutBon Natural Life Limited (“BON”)
BON is a Cayman Islands company engaged in the business of natural, health, and personal care industries. For more information, please visit the Company’s website at http://www.bnlus.com.
For more information, please contact:
Cindy Liu | IR
Email: [email protected]
SafeHarbor Statement
This press release contains certain statements that may include “forward-looking statements.” All statements other than statements of historical fact included herein are “forward-looking statements.” These forward-looking statements are often identified by the use of forward-looking terminology such as “believes,” “expects” or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, they do involve assumptions, risks, and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company’s periodic reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.